Cohorts for the study of HIV-1—exposed but uninfected individuals: benefits and limitations

dc.contributor.author	Horton, RE
dc.contributor.author	McLaren, PJ
dc.contributor.author	Fowke, K
dc.contributor.author	Kimani, J
dc.contributor.author	Ball, T Blake
dc.date.accessioned	2015-05-19T08:41:34Z
dc.date.available	2015-05-19T08:41:34Z
dc.date.issued	2010
dc.identifier.citation	J Infect Dis. (2010) 202 (Supplement 3): S377-S381. doi: 10.1086/655971	en_US
dc.identifier.uri	http://jid.oxfordjournals.org/content/202/Supplement_3/S377.short
dc.identifier.uri	http://hdl.handle.net/11295/83150
dc.description.abstract	Since the late 1980s, with the first identification of individuals who were exposed to human immunodeficiency virus type 1 (HIV-1) yet remained uninfected, or “HIV-1—resistant” individuals, a large number of cohorts that include HIV-exposed seronegative (HESN) subjects have been identified globally for the purpose of investigating the genetic, immunologic, and environmental factors that may help alter susceptibility to HIV-1. In this article, in light of the recent International Symposium on Natural Immunity to HIV, we review the characteristics of different groups with respect to their relative risks and briefly summarize the known cohorts that include exposed uninfected subjects worldwide.	en_US
dc.language.iso	en	en_US
dc.publisher	Univerisyt of Nairobi	en_US
dc.title	Cohorts for the study of HIV-1—exposed but uninfected individuals: benefits and limitations	en_US
dc.type	Article	en_US
dc.type.material	en	en_US